Traditional bond investors have lost money for years. These five-star portfolio managers show a better way.

Virgin Galactic outlines plan to lift capacity to 150 flights per year as commercial service shifts to early Q2 2027

NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M

Cibus targets biofragrance peak revenue up to $100M while aiming for rice launch as early as 2028

Cytosorbents outlines early 2027 DrugSorb-ATR De Novo plan with $300M initial U.S./Canada market